Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tentarix Biotherapeutics
Biotech
Canadian VC Amplitude unveils $192M biotech fund
Repare Therapeutics backer Amplitude Ventures has unveiled a second fund, securing $192 million for the development of new precision medicines.
Gabrielle Masson
May 29, 2024 10:30am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am
AbbVie wraps up $64M oncology, immunology deal with Tentarix
Feb 22, 2024 9:09am
Gilead, Tentarix ink $66M oncology, inflammatory disease deal
Aug 15, 2023 10:22am
Seasoned executive team launches Tentarix with $50M
Oct 14, 2021 2:31pm
